• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性淋巴细胞白血病的预后因素——特别考虑症状出现至诊断前的持续时间(作者译)

[Prognostic factors in acute lymphoblastic leukaemia--with special consideration of pre-diagnostic duration of signs (author's transl)].

作者信息

Schwenk H U, Seiler G, Engelhardt K, Kühner U

出版信息

Klin Padiatr. 1980 Jan;192(1):39-44. doi: 10.1055/s-2008-1033857.

DOI:10.1055/s-2008-1033857
PMID:6928499
Abstract

It is concluded from the prognostic factors of acute lymphoblastic leukaemia, as far as they have become known up to now, such as initial leukocyte count, extent of organ infiltration, etc, that the pre-diagnostic duration of signs, representing a measure of the proliferation activity of the leukaemia cells, could also represent a relevant prognostic characteristic. A check conducted in 90 children treated between 1966--1975 yields a correlation only between a very short pre-diagnostic duration of signs (less than 2 weeks) and the duration of the first complete remission (as well as the survival time). However, even those prognostic factors which are already generally recognised, possess merely limited reliability, because they do not take the individual response to therapy into account. Hence, improvement of prognosis of the course of the disease can be expected only if the continuous decrease of the remaining population of blasts during the early phase of remission can be determined with greater accuracy than before.

摘要

从急性淋巴细胞白血病的预后因素来看,就目前所知,如初始白细胞计数、器官浸润程度等,症状出现前的持续时间作为白血病细胞增殖活性的一种度量,也可能是一个相关的预后特征。对1966年至1975年间接受治疗的90名儿童进行的一项检查发现,只有症状出现前持续时间非常短(少于2周)与首次完全缓解的持续时间(以及生存时间)之间存在相关性。然而,即使是那些已被普遍认可的预后因素,其可靠性也仅有限,因为它们没有考虑个体对治疗的反应。因此,只有在缓解早期能够比以前更准确地确定残留原始细胞群体的持续减少情况时,才有望改善疾病进程的预后。

相似文献

1
[Prognostic factors in acute lymphoblastic leukaemia--with special consideration of pre-diagnostic duration of signs (author's transl)].急性淋巴细胞白血病的预后因素——特别考虑症状出现至诊断前的持续时间(作者译)
Klin Padiatr. 1980 Jan;192(1):39-44. doi: 10.1055/s-2008-1033857.
2
[Acute lymphoblastic leukemia in childhood: importance of sex as a prognostic factor (author's transl)].
Arch Fr Pediatr. 1982 Jan;39(1):17-21.
3
Prognostic factors in children with acute lymphoblastic leukemia. Part I: Univariate analysis. Children's Cancer and Leukemia Study Group.急性淋巴细胞白血病患儿的预后因素。第一部分:单变量分析。儿童癌症与白血病研究组。
Jpn J Clin Oncol. 1985 Mar;15(1):3-12.
4
Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL).形态学(FAB分类)在儿童急性淋巴细胞白血病(ALL)中的预后重要性。
Br J Haematol. 1981 Jun;48(2):199-206.
5
Prognostic factors in children with acute lymphoblastic leukemia. Part II: Multivariate analysis. Children's Cancer and Leukemia Study Group.急性淋巴细胞白血病患儿的预后因素。第二部分:多变量分析。儿童癌症与白血病研究组
Jpn J Clin Oncol. 1985 Mar;15(1):13-23.
6
Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.儿童急性淋巴细胞白血病的免疫学分型:其与临床表现特征及预后的关系
Br J Haematol. 1981 Jun;48(2):179-97.
7
[Factors influencing outcome in children with acute lymphoblastic leukemia (author's transl)].[影响急性淋巴细胞白血病患儿预后的因素(作者译)]
An Esp Pediatr. 1976 Jun;9(4 Suppl):35-40.
8
[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].
Klin Padiatr. 1987 May-Jun;199(3):151-60. doi: 10.1055/s-2008-1026781.
9
[Concepts in therapy of the first relapse in acute lymphoblastic leukaemia: experience with 28 children (author's transl)].急性淋巴细胞白血病首次复发的治疗理念:28例儿童的经验(作者译)
Klin Padiatr. 1977 Jan;189(8):41-3.
10
Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.在急性淋巴细胞白血病维持治疗中,长春新碱-泼尼松交替脉冲联合阿糖胞苷-环磷酰胺与长春新碱-泼尼松的比较
Cancer Treat Rep. 1984 Apr;68(4):581-6.